94 related articles for article (PubMed ID: 8025586)
1. Injections of complexes made of dsDNA and specific polyclonal antibodies extend MRL lpr mouse survival: a pilot study.
Lebrun P; Burny W; Cosyns JP; Saint-Remy JM
Lupus; 1994 Feb; 3(1):47-53. PubMed ID: 8025586
[TBL] [Abstract][Full Text] [Related]
2. Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice.
Burny W; Lebrun P; Cosyns JP; Saint-Remy JM
Lupus; 1997; 6(1):4-17. PubMed ID: 9116717
[TBL] [Abstract][Full Text] [Related]
3. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
[TBL] [Abstract][Full Text] [Related]
4. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus disease.
Lake RA; Staines NA
Clin Exp Immunol; 1988 Jul; 73(1):103-10. PubMed ID: 3048810
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T
J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effect of total glucosides of paeony on lupus nephritis in MRL/lpr mice].
Ding ZX; Yang SF; Wu QF; Lu Y; Chen YY; Nie XL; Jie HY; Qi JM; Wang FS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):656-60. PubMed ID: 21515463
[TBL] [Abstract][Full Text] [Related]
8. Human and murine anti-DNA antibodies induce the production of anti-idiotypic antibodies with autoantigen-binding properties (epibodies) through immune-network interactions.
Puccetti A; Migliorini P; Sabbaga J; Madaio MP
J Immunol; 1990 Dec; 145(12):4229-37. PubMed ID: 2258615
[TBL] [Abstract][Full Text] [Related]
9. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria.
Amoura Z; Chabre H; Koutouzov S; Lotton C; Cabrespines A; Bach JF; Jacob L
Arthritis Rheum; 1994 Nov; 37(11):1684-8. PubMed ID: 7980678
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal anti-double stranded DNA antibody from an autoimmune MRL/Mp-lpr/lpr mouse: specificity and idiotype in serum immunoglobulins.
Kubota T; Akatsuka T; Kanai Y
Immunol Lett; 1986 Nov; 14(1):53-8. PubMed ID: 3492443
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
12. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice.
Fenton KA; Tømmerås B; Marion TN; Rekvig OP
Autoimmunity; 2010 Mar; 43(2):179-88. PubMed ID: 19835488
[TBL] [Abstract][Full Text] [Related]
13. Increased responsiveness of B. cells in the murine MRL/lpr model of lupus nephritis to interleukin-1 beta.
Lebedeva TV; Singh AK
J Am Soc Nephrol; 1995 Jan; 5(7):1530-4. PubMed ID: 7703391
[TBL] [Abstract][Full Text] [Related]
14. Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice.
Ben-Yehuda A; Bar-Tana R; Livoff A; Ron N; Cohen IR; Naparstek Y
Lupus; 1996 Jun; 5(3):232-6. PubMed ID: 8803896
[TBL] [Abstract][Full Text] [Related]
15. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
Jabs DA; Kuppers RC; Saboori AM; Burek CL; Enger C; Lee B; Prendergast RA
Cell Immunol; 1994 Mar; 154(1):66-76. PubMed ID: 7907009
[TBL] [Abstract][Full Text] [Related]
16. Involvement in lupus disease of idiotypes Id.F-423 and Id.IV-228 defined, respectively, upon foetal and adult MRL/Mp-lpr/lpr DNA-binding monoclonal autoantibodies.
Ravirajan CT; Staines NA
Immunology; 1991 Oct; 74(2):342-7. PubMed ID: 1748483
[TBL] [Abstract][Full Text] [Related]
17. ALW peptide ameliorates lupus nephritis in MRL/lpr mice.
Wang H; Lu M; Zhai S; Wu K; Peng L; Yang J; Xia Y
Arthritis Res Ther; 2019 Dec; 21(1):261. PubMed ID: 31791413
[TBL] [Abstract][Full Text] [Related]
18. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
[TBL] [Abstract][Full Text] [Related]
19. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
20. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
